| pubmed-article:17176221 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17176221 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:17176221 | lifeskim:mentions | umls-concept:C1879526 | lld:lifeskim |
| pubmed-article:17176221 | lifeskim:mentions | umls-concept:C0087096 | lld:lifeskim |
| pubmed-article:17176221 | lifeskim:mentions | umls-concept:C0205430 | lld:lifeskim |
| pubmed-article:17176221 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17176221 | pubmed:dateCreated | 2006-12-19 | lld:pubmed |
| pubmed-article:17176221 | pubmed:abstractText | Gamma (gamma) tocopherol, but not alpha (alpha) tocopherol (vitamin E), has previously been reported as an effective inhibitor of cyclooxygenase (COX) enzyme activity. In a pilot study of 17 rats, mixed tocopherols containing more than 50% gamma-tocopherol, added at 0.1% to an AIN-76A diet, produced a significant inhibition (about 55%) of azoxymethane-induced aberrant crypt foci in the colon of rats. Mixed tocopherols also reduced tetradecanoyl phorbol acetate-induced ear inflammation in mice when topically applied. | lld:pubmed |
| pubmed-article:17176221 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17176221 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17176221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17176221 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17176221 | pubmed:issn | 0163-5581 | lld:pubmed |
| pubmed-article:17176221 | pubmed:author | pubmed-author:ReddyBandaru... | lld:pubmed |
| pubmed-article:17176221 | pubmed:author | pubmed-author:HuangMou-Tuan... | lld:pubmed |
| pubmed-article:17176221 | pubmed:author | pubmed-author:NewmarkHarold... | lld:pubmed |
| pubmed-article:17176221 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17176221 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:17176221 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17176221 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17176221 | pubmed:pagination | 82-5 | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:meshHeading | pubmed-meshheading:17176221... | lld:pubmed |
| pubmed-article:17176221 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17176221 | pubmed:articleTitle | Mixed tocopherols inhibit azoxymethane-induced aberrant crypt foci in rats. | lld:pubmed |
| pubmed-article:17176221 | pubmed:affiliation | Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Rutgers-The State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ 08854-8020, USA. florek@rci.rutgers.edu | lld:pubmed |
| pubmed-article:17176221 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17176221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17176221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17176221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17176221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17176221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17176221 | lld:pubmed |
